Effects of the long-term storage of human fecal microbiota samples collected in RNAlater.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
24 01 2019
Historique:
received: 29 08 2018
accepted: 23 11 2018
entrez: 26 1 2019
pubmed: 27 1 2019
medline: 1 8 2020
Statut: epublish

Résumé

The adequate storage of fecal samples from clinical trials is crucial if analyses are to be performed later and in long-term studies. However, it is unknown whether the composition of the microbiota is preserved during long-term stool storage (>1 year). We therefore evaluated the influence of long-term storage on the microbiota composition of human stool samples collected in RNAlater and stored for approximately five years at -80 °C. We compared storage effects on stool samples from 24 subjects with the effects of technical variation due to different sequencing runs and biological variation (intra- and inter-subject), in another 101 subjects, based on alpha-diversity, beta-diversity and taxonomic composition. We also evaluated the impact of initial alpha-diversity and fecal microbiota composition on beta-diversity instability upon storage. Overall, long-term stool storage at -80 °C had only limited effects on the microbiota composition of human feces. The magnitude of changes in alpha- and beta- diversity and taxonomic composition after long-term storage was similar to inter-sequencing variation and smaller than biological variation (both intra- and inter-subject). The likelihood of fecal samples being affected by long-term storage correlated with the initial relative abundance of some genera and tend to be affected by initial taxonomic richness.

Identifiants

pubmed: 30679604
doi: 10.1038/s41598-018-36953-5
pii: 10.1038/s41598-018-36953-5
pmc: PMC6345939
doi:

Substances chimiques

RNA, Ribosomal, 16S 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

601

Références

Appl Environ Microbiol. 2004 Dec;70(12):7220-8
pubmed: 15574920
Appl Environ Microbiol. 2005 Dec;71(12):8228-35
pubmed: 16332807
PLoS One. 2008 Jul 30;3(7):e2836
pubmed: 18665274
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
BMC Microbiol. 2010 Jul 30;10:206
pubmed: 20673359
Nature. 2011 May 12;473(7346):174-80
pubmed: 21508958
Nature. 2012 Jun 13;486(7402):215-21
pubmed: 22699610
BMC Microbiol. 2012 Jul 30;12:158
pubmed: 22846661
Nature. 2012 Sep 13;489(7415):242-9
pubmed: 22972297
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
Gastroenterology. 2013 Jun;144(7):1394-401, 1401.e1-4
pubmed: 23474283
Genome Res. 2013 Oct;23(10):1704-14
pubmed: 23861384
Gastroenterology. 2014 May;146(6):1449-58
pubmed: 24486050
Cell. 2014 Mar 27;157(1):121-41
pubmed: 24679531
BMC Microbiol. 2014 Apr 23;14:103
pubmed: 24758293
Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):E2329-38
pubmed: 24843156
Genome Biol. 2014;15(7):R89
pubmed: 25146375
Cell. 2014 Oct 9;159(2):227-30
pubmed: 25303518
Genome Biol. 2014;15(12):550
pubmed: 25516281
Genome Biol. 2015 Apr 08;16:73
pubmed: 25888008
FASEB J. 2015 Aug;29(8):3111-23
pubmed: 25921831
PLoS One. 2015 May 29;10(5):e0126685
pubmed: 26024217
PLoS One. 2015 Aug 07;10(8):e0134802
pubmed: 26252519
Microbiome. 2015 Aug 12;3:33
pubmed: 26269741
Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):407-16
pubmed: 26604270
J Microbiol Methods. 2016 Apr;123:31-8
pubmed: 26853125
Nat Methods. 2016 May;13(5):435-8
pubmed: 26999001
Microbiome. 2016 May 10;4(1):19
pubmed: 27160322
Sci Rep. 2016 May 26;6:26648
pubmed: 27226242
Microbiome. 2016 Jul 30;4(1):40
pubmed: 27473284
PLoS One. 2016 Oct 4;11(10):e0163666
pubmed: 27701448
Gastroenterology. 2017 Jan;152(1):111-123.e8
pubmed: 27725146
Genome Biol. 2016 Oct 19;17(1):217
pubmed: 27760558
PeerJ. 2016 Oct 18;4:e2584
pubmed: 27781170
mSystems. 2016 May 3;1(3):
pubmed: 27822526
Nat Microbiol. 2017 Feb 13;2:17004
pubmed: 28191884
Front Microbiol. 2017 Jan 31;8:102
pubmed: 28197142
Environ Microbiol. 2017 Apr;19(4):1379-1390
pubmed: 28198087
Microbiome. 2017 Mar 3;5(1):27
pubmed: 28253908
Microbiome. 2017 May 5;5(1):52
pubmed: 28476139
FEMS Microbiol Rev. 2017 Aug 1;41(Supp_1):S154-S167
pubmed: 28830090
Science. 2017 Aug 25;357(6353):802-806
pubmed: 28839072
Nat Microbiol. 2018 Mar;3(3):347-355
pubmed: 29335554

Auteurs

Julien Tap (J)

Danone Nutricia Research, Innovation, Science and Nutrition Department, RD 128 - Avenue de la Vauve, 91767, Palaiseau, France.

Stéphanie Cools-Portier (S)

Danone Nutricia Research, Innovation, Science and Nutrition Department, RD 128 - Avenue de la Vauve, 91767, Palaiseau, France.

Sonia Pavan (S)

SPScienceCom, Paris, France.

Anne Druesne (A)

Danone Nutricia Research, Innovation, Science and Nutrition Department, RD 128 - Avenue de la Vauve, 91767, Palaiseau, France.

Lena Öhman (L)

Department of Immunology and Microbiology, Inst. of Biomedicine, University of Gothenburg, Gothenburg, Sweden.
Department of Internal Medicine and Clinical Nutrition, Inst. Of Medicine, University of Gothenburg, Gothenburg, Sweden.

Hans Törnblom (H)

Department of Internal Medicine and Clinical Nutrition, Inst. Of Medicine, University of Gothenburg, Gothenburg, Sweden.

Magnus Simren (M)

Department of Internal Medicine and Clinical Nutrition, Inst. Of Medicine, University of Gothenburg, Gothenburg, Sweden.
Center for Functional Gastrointestinal and Motility Disorders, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Muriel Derrien (M)

Danone Nutricia Research, Innovation, Science and Nutrition Department, RD 128 - Avenue de la Vauve, 91767, Palaiseau, France. muriel.derrien@danone.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH